These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9592705)

  • 1. [The role of endothelial function for ischemic manifestations of coronary atherosclerosis].
    Britten M; Schächinger V
    Herz; 1998 Mar; 23(2):97-105. PubMed ID: 9592705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis-associated endothelial dysfunction.
    Schächinger V; Zeiher AM
    Z Kardiol; 2000; 89 Suppl 9():IX/70-4. PubMed ID: 11151799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of endothelial modulation of coronary vasomotor tone: insights into a fundamental functional disturbance in vascular biology of atherosclerosis.
    Zeiher AM; Schächinger V; Saurbier B; Just H
    Basic Res Cardiol; 1994; 89 Suppl 1():115-28. PubMed ID: 7945166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
    Britten MB; Zeiher AM; Schächinger V
    J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease.
    Egashira K
    Circ J; 2002 Jun; 66(6):529-33. PubMed ID: 12074266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.
    Zeiher AM; Drexler H; Wollschläger H; Just H
    Circulation; 1991 Feb; 83(2):391-401. PubMed ID: 1991363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial therapy of atherosclerosis and its risk factors.
    Traupe T; Ortmann J; Münter K; Barton M
    Curr Vasc Pharmacol; 2003 Jun; 1(2):111-21. PubMed ID: 15320838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans.
    Al-Shaer MH; Choueiri NE; Correia ML; Sinkey CA; Barenz TA; Haynes WG
    Int J Cardiol; 2006 May; 109(2):201-6. PubMed ID: 16054252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning.
    Pagliaro P; Chiribiri A; Mancardi D; Rastaldo R; Gattullo D; Losano G
    Ital Heart J; 2003 Jun; 4(6):383-94. PubMed ID: 12898803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endothelial regulation of coronary circulation: current status].
    Schächinger V; Zeiher AM
    Z Kardiol; 1996; 85 Suppl 6():263-7. PubMed ID: 9064975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.
    Quyyumi AA
    J Am Coll Cardiol; 1998 Oct; 32(4):904-11. PubMed ID: 9768710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial dysfunction--assessment of current status and approaches to therapy].
    Simon BC; Noll B; Maisch B
    Herz; 1999 Feb; 24(1):62-71. PubMed ID: 10093015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.
    Heitzer T; Ollmann I; Köke K; Meinertz T; Munzel T
    Circulation; 2003 Aug; 108(5):536-41. PubMed ID: 12874186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic options for improvement of myocardial perfusion in coronary atherosclerosis].
    Schächinger V
    Herz; 1998 Mar; 23(2):116-29. PubMed ID: 9592707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in atherosclerosis.
    Harrison DG
    Basic Res Cardiol; 1994; 89 Suppl 1():87-102. PubMed ID: 7945179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.